Piper chaba

Piper chaba (Hunter): A Comprehensive Reference

1. Identity, Taxonomy, and Botanical Description

Accepted name: Piper chaba W. Hunter (sometimes written Piper chaba Hunter). Piper chaba W. Hunter is listed in authoritative taxonomic databases as a synonym of the currently accepted name Piper retrofractum Vahl. Additional synonyms in common scientific use include Piper retrofractum Vahl, Piper officinarum C.DC., and Piper chaba Hunter. The species belongs to the family Piperaceae, an economically and ecologically important family containing about 1,000–2,000 species of plants.

Piper retrofractum (the accepted name) is a flowering vine in the family Piperaceae, cultivated for its fruit, which is usually dried and used as a spice and seasoning, and is native to Java island in Indonesia. The plant is a dioecious, evergreen climbing shrub native to Southeast Asia, including the Philippines, Indonesia, Malaysia, Thailand, Vietnam, Cambodia, Laos, and southern China. This liana grows up to 10 meters long, supported by adhesive roots, with glabrous, coriaceous leaves that are ovate to oblong, measuring 8–20 cm long and 3–13 cm wide, often featuring sunken gland dots. Its erect or patent spikes produce cylindrical infructescences 2–4 cm long, bearing connate berries that are green and pungent when unripe, turning red-brown upon maturity. The plant thrives in wet tropical biomes, particularly in deciduous forests on poor soils up to 600 m altitude, thickets at low elevations, and even along beaches.

As a member of the Piperaceae family, the flowering vine is reported to be grown in Indonesia, Singapore, Sri Lanka, Bangladesh, and some parts of India, including Tripura, Kerala, and West Bengal. Piper chaba is an evergreen climbing shrub in the family Piperaceae, typically reaching heights of 2–4 meters. It exhibits a scandent growth habit, often spreading on the ground as a creeper or climbing on supporting trees and structures via adventitious roots along its stems. The stems are slender, terete, and striated, measuring approximately 2 mm in thickness when dry.

Common Names

The medicinal plant is known as Chuijhal in Bangladesh, Tripura (India), and West Bengal (India). In Cambodia, it is known as dei-phlei and in Thailand as deebplee. In English, it is called Java Long Pepper root or Balinese pepper; in Hindi it is Chaba, chavya, or Chabha; in Telugu Chavakam, Sevamu, or chavyamu; in Bengali Chayi, choyi, or chear; and in Tamil Chavyam. In Ayurvedic literature the plant is called Chavya or Chavika. In the Malay Archipelago, the fruit was once known as cabai; however, its culinary popularity was superseded by the chilli, brought over from the New World by European traders, resulting in a semantic shift in which the new crop became cabai, and the old became cabai jawa.

Taxonomic Note

In Ayurvedic literature and herbal trade, Piper retrofractum is generally accepted as a synonym or botanical equivalent of Piper chaba, especially when referring to Chavya. Chavya (Piper chaba) is an important medicinal plant of Ayurveda. Modern botanical evaluation supports its placement in the genus Piper, and it is widely accepted as Piper chaba, with both stem and fruit used medicinally. Piper retrofractum is distinguished from the closely related Piper longum (Indian long pepper) by its Southeast Asian origin, as opposed to the South Asian distribution of P. longum, along with differences in fruit morphology, such as the more curved spikes in P. retrofractum, and variations in microscopic stem and root structures observable via transverse sections.

2. Common Forms and Preparations

The stem of the P. chaba plant is locally known as "Chuijhal" and is used as a spice. Bangladesh is endowed with an abundance of these excellent medicinal plant resources. Though the roots have a stronger scent than the stems, they are nonetheless costlier than the stems in Bangladesh. The leaves, stems, and seeds of medicinal piper species are widely grown for their strong scent and acrid taste, which makes them valuable spices.

The plant is prepared and used in multiple forms:

• Dried stem and root powder (Churna): Decoctions of chavya roots and stems are boiled in water and consumed to relieve colic, poisoning, and anorexia, with typical dosages reported from traditional use ranging from 1–3 grams of powder daily or 50–100 ml of decoction.
• Methanolic, ethanolic, and aqueous extracts: These are the primary preparations used in scientific studies. In order to rationalize the ethnomedical uses, the methanol extract of the stem bark has been subjected to pharmacological evaluation for analgesic, anti-inflammatory, diuretic, anti-diarrhoeal, effect on gastrointestinal motility, and CNS depressant activity in mice and rats at 125, 250, and 500 mg/kg body weight doses.
• Essential oil / petroleum ether and chloroform extracts: Used in research studies examining volatile components and antimicrobial activity.
• Topical preparations: Oil extracts derived from the plant are applied topically for skin ailments like itching and disorders, providing antimicrobial and soothing effects.
• Classical Ayurvedic compound formulations: Ayurvedic medicines containing Chavya as an ingredient include Chavikasavam (used in UTI, cough, cold, and gout), Saptavinshati Guggulu (for wound healing, sinuses, and skin diseases), and Panchakola Ghrita (for cold, cough, asthma, fever, spleen disorders, indigestion, and anemia).

3. Traditional and Historical Use

Ayurveda (India, first millennium BCE onward)

Traditional practice of Āyurveda in ancient India dates back to at least the first millennium BC. Chavya (Piper chaba), a climbing shrub belonging to the Piperaceae family, is a well-known medicinal plant in Ayurveda. It is closely related to other Piper species like Piper longum and Piper nigrum. In classical texts, Chavya is valued for its Deepana (appetizer), Pachana (digestive), and Vata-Kapha balancing properties.

It is mainly used in digestive disorders such as indigestion, abdominal pain, bloating, constipation, and Ama (toxins due to weak digestion). Due to its Ushna (hot) potency and Tikshna (sharp) nature, it stimulates Agni (digestive fire) and enhances metabolism. Chavya is also included in several classical formulations for Grahani (malabsorption syndrome) and Shoola (colicky pain).

Piper chaba is listed as one of the five Pañcakola in the ancient Garuḍapurāṇa, where it is used in the treatment of elephants (Gajāyurveda or Hastyāyurveda). The Pañcakola compound consisted of Piper longum, its root, Piper chaba, Piper cubeba, and dried ginger.

The name "Chavya" is derived from a root word meaning "to chew," referring to the herb's traditional use as a medicinal chew or a pungent spice. There are differing opinions among Ayurvedic scholars regarding the identity of Chavya and Gajapippali. According to Bhavaprakasha, Gajapippali is described as the fruit of Chavya. Some scholars like Chopra and Nadkarni have accepted Chavya and Gajapippali as the same plant, while other scholars have considered them as two distinct plants. Due to this confusion, both are categorized under controversial/doubtful drugs.

Unani Medicine and South Asian Folk Medicine

Piper chaba has a rich history of medicinal use across South and Southeast Asia. Traditionally, it has been treasured in Ayurvedic, Unani, and folk medicine systems. The dried fruit spikes and roots were widely incorporated into remedies aimed at stimulating digestion, relieving respiratory disorders, and enhancing overall vitality. Its warming, pungent qualities made it especially valuable for treating colds, coughs, bronchitis, and throat infections.

Thai Traditional Medicine

P. chaba Hunt. is used as an ingredient in Thai traditional preparation for arthritis. Its isolated compound is piperine, which shows anti-inflammatory activity.

Bangladesh and India — Contemporary Folk Use

Piper chaba (locally known as "Choi Jhal") is used traditionally as spices and folk medicine in different parts of Bangladesh. Piper chaba Hunter (Piperaceae) is a common pepper in the southern part of Bangladesh. Various parts of this plant have been extensively used in different traditional formulations including Ayurveda.

In Ayurveda, Piper chaba, known as chavya, is valued for its pungent and heating properties, which balance Vata and Kapha doshas while stimulating digestion and metabolism. It is traditionally employed to alleviate indigestion, abdominal pain, colic, and respiratory issues such as cough and asthma, often through the use of its roots and fruits in herbal formulations. The roots are particularly used to prepare anti-inflammatory teas that soothe joint pain and inflammation, while the fruits aid in detoxification by countering toxins and worm infestations.

Fruits of Piper longum (Indian tipali) and Piper chaba (Bangla tipali) are widely used in traditional Indian systems of medicine, and the latter is considered as a substitute for the former.

4. Key Constituents and Active Compounds

A number of important phytoconstituents such as dimeric alkaloids and alkamides have been isolated from various parts of P. chaba. The principal and best-characterized classes of bioactive compounds include:

Alkaloids and Amide Alkaloids

• Piperine: Piperine is one of the most important bioactive compounds in this plant. GC–MS analysis of samples from northern India revealed that piperine represented 46.69% of phytochemical content, making it the most prominent compound. Piperine is a type of amide alkaloid that exhibits pleiotropic properties including antioxidant, anticancer, anti-inflammatory, antihypertensive, hepatoprotective, neuroprotective, and bioavailability-enhancing activities.
• Chabamide: A unique piperine dimer called chabamide has been isolated from the stem bark of Piper chaba. Chabamide exhibited significant inhibitory activity on lipopolysaccharide-induced nitric oxide (NO) production in RAW264.7 cells, with an IC₅₀ value of 6.8 μM, and inhibited NO production in bone marrow-derived macrophages with an IC₅₀ value of 9.5 μM. Treatment of cells with chabamide suppressed expression of inducible NO synthase and cyclooxygenase-2.
• Retrofractamides A and B: Other chemical compounds of P. chaba including retrofractamide B, as well as brachystamide B, dehydropipernonaline, fragaramide, guineensine, methyl piperate, isopiperine, isochavicine, piperonal, and piperlonguminine, could activate the TRPV1 channel. Retrofractamide A from Piper chaba has been shown to enhance adipogenesis in 3T3-L1 cells, increasing adiponectin levels and glucose uptake. Piperlonguminine similarly promotes mRNA expressions linked to fat cell differentiation.
• Piplartine (piperlongumine): Isolated from the roots alongside piperine and piperlonguminine. Some alkamides reported to be present in the root of Piper chaba include piperine, piplartine, piperlonguminine, sylvatine, and β-sitosterol.
• Pipernonaline and dehydropipernonaline
• Pellitorine, guineensine, and isopiperolein B
• Chabamide I and Chingchengenamide A: Two alkaloids isolated from P. chaba are Chabamide I and Chingchengenamide A. Chingchengenamide A is a derivative of piperine. Structure–activity relationship studies showed that this compound has greater biological activity than piperine. Both alkaloids Chabamide I and Chingchengenamide A demonstrated inhibitory effectiveness against at least one of eight tested human tumor cell lines.
• N-isobutyl-(2E,4E)-octadecadienamide and N-isobutyl-(2E,4E,14Z)-eicosatrienamide
• Bornyl piperate and piperlonguminine (isolated from roots): The petroleum ether and chloroform extracts of the root of Piper chaba showed antimicrobial, antileishmanial and cytotoxic activities; bioactivity-guided fractionation led to the isolation of bornyl piperate, piperlonguminine, and piperine.

Polyphenols and Other Secondary Metabolites

• Chlorogenic acid, gallic acid, quercetin, and naringenin have been identified and quantified from P. chaba stem extracts.
• Other prominent compounds identified by GC–MS include kusunokinin (8.9%) and sitostenone (7.57%). The plant has shown good nutritional value including iron (11.25 mg), calcium (147 mg), and vitamin C (9.30 mg) per 100 g, with a higher phenolic content than other species (~13.75 g/100 g plant powder).

Volatile / Essential Oil Constituents

The leaf oil of P. chaba is rich in sesquiterpene hydrocarbons β-caryophyllene (28.6%), α-humulene (22.8%), and germacrene D (14.6%). The fruit oil mainly contains sesquiterpene hydrocarbons such as germacrene D (21.5%), β-caryophyllene (18.5%), and α-humulene (11.4%).

Polyphenolic Phytochemical Summary

Fractionated quantitative biochemical analysis of P. chaba revealed that fractions contained substantial amounts of phenolics (ranging from 863.75 mg to 1073.11 mg GAE/g of dry extract), flavonoids (164.01 mg to 244.57 mg QE/g of dry weight), and tannins (42.86 mg to 64.88 mg TAE/g dry extract).

5. Mechanisms of Action

TRPV1 Receptor Activation

Piperine, the isolated compound, shows anti-inflammatory activity. Piperine produces a burning sensation because it activates the TRPV1 receptor. TRPV1 activation is involved with the analgesic and adjuvant effect. P. chaba extract induced calcium influx in TRPV1-expressing cells with an EC₅₀ value of 0.67 μg/ml. Piperine induced calcium influx with an EC₅₀ value of 0.31 μg/ml or 1.08 μM. PC extract samples with lower piperine content gave rise to a stronger TRPV1 response than pure piperine, suggesting that TRPV1 receptor was activated not only by piperine but also by other compounds in the extract including brachystamide B, dehydropipernonaline, fragaramide, guineensine, methyl piperate, isopiperine, isochavicine, piperonal, piperlonguminine, and retrofractamide. These compounds may show a synergistic effect on TRPV1 activation.

Anti-inflammatory Mechanisms

Chabamide exhibited significant inhibitory activity on lipopolysaccharide-induced NO production in macrophages and suppressed expression of inducible NO synthase and cyclooxygenase-2, which are key mediators of inflammation. Piperine itself exhibits pleiotropic anti-inflammatory properties and has the ability to alter gastrointestinal disorders, drug-metabolizing enzymes, and the bioavailability of several drugs.

CYP2E1 Inhibition (Hepatoprotective Mechanism)

GC–MS analysis of P. chaba extract is enriched in fatty acid methyl esters (46.23%) and alkaloids (10.91%), and piperine is represented as the main phytochemical. Among all identified phytochemicals, piperine (−8.0 kcal/mol) was found to be the most interactive and stable at the binding site of CYP2E1 — the enzyme responsible for paracetamol (acetaminophen) bioactivation into its hepatotoxic metabolite.

Antidiabetic Mechanisms

The antidiabetic potential, assessed by IC₅₀ for the α-amylase assay, was found to be 23.09 ± 0.3 μg/ml. Molecular docking revealed that kusunokinin showed strong binding affinity toward α-amylase. α-Amylase and α-glucosidase inhibition assays were performed to assess in vitro antidiabetic activity; the methanolic extract of P. chaba stem (PCME) showed inhibitory activity with IC₅₀ values of 108.89 μg/ml and 127.28 μg/ml for α-amylase and α-glucosidase, respectively.

Anticancer / Apoptotic Mechanisms

The stem methanolic extract significantly arrests T47D (luminal breast cancer) cells at the G0/G1 phase by reducing CCND1 and CDK4 expression at mRNA and protein levels. Extract treatment significantly altered nuclear morphology, mitochondrial membrane potential, and production of reactive oxygen species. The extract significantly altered the Bax/Bcl-2 ratio and caspase 8 and 3 mRNA/protein levels, indicating induction of intrinsic apoptosis.

Adipogenic Mechanism

Retrofractamide A from Piper chaba enhances adipogenesis in 3T3-L1 cells, increasing adiponectin levels and glucose uptake. Piperlonguminine similarly promotes mRNA expressions linked to fat cell differentiation.

6. Scientific Evidence by Area of Use

Important caveat: The overwhelming majority of the scientific evidence base for Piper chaba currently consists of in vitro (cell-based) and in vivo (animal) preclinical studies, plus molecular docking/computational analyses. No clinical trials (randomized controlled trials in humans) specifically evaluating Piper chaba as a supplement have been identified in the peer-reviewed literature as of 2024–2025. This is explicitly noted where relevant.

6.1 Anti-inflammatory and Analgesic Activity

Evidence level: Preclinical (animal and cell-based), no human trials identified.

A well-known traditional medicinal plant Piper chaba H. from the Piperaceae family is rich in bioactive phytochemicals that have antidiarrheal, antimicrobial, analgesic, antioxidant, anticancer, and cytotoxic effects.

A 2020 study published in BMC Complementary Medicine and Therapies (PMC7201532) investigated TRPV1 receptor activation. The study investigated the effect of P. chaba extract and piperine on the TRPV1 receptor, which is considered a target for analgesic effects, and examined adjuvant effects by a fluorescein isothiocyanate (FITC)-induced contact hypersensitivity (CHS) model in mice. For the mouse CHS model, 1% piperine, 5% piperine, 1% P. chaba extract, and 5% P. chaba extract significantly enhanced sensitization to FITC as revealed by ear swelling responses. The conclusion was that P. chaba extract and piperine activated the TRPV1 channel and enhanced contact sensitization to FITC. These are all preclinical findings and do not establish clinical efficacy in humans.

Methanolic and aqueous extracts showed significantly higher total phenolic and flavonoid content. Significantly potential antioxidant, antidiabetic, and anti-inflammatory activities were shown by the methanolic extract of P. chaba in preclinical assays.

6.2 Antimicrobial Activity

Evidence level: Preclinical in vitro studies only.

Antibacterial and antifungal properties of petroleum ether, chloroform, ethyl acetate, and methanol extracts of Piper chaba roots were studied by disc diffusion method; the extracts were found to exhibit promising antibacterial and antifungal properties against Gram-positive, Gram-negative bacteria, and fungi.

Among four tested bacterial strains, the extract was most responsive toward Escherichia coli (zone of inhibition 35 ± 0.68 mm), which exceeded the standard antibiotic control. Among two tested fungal strains, Saccharomyces cerevisiae showed the best zone of inhibition (27.5 ± 0.8 mm), greater than that of the standard amphotericin (20.25 ± 0.28 mm).

All fractions of P. chaba revealed strong fungicidal activity with Inhibition Zone Diameter (IZD) ranging from 32.49 to 36.66 mm, except the acetone fraction. The strength of this evidence is limited to in vitro disk diffusion studies and cannot be extrapolated to clinical infection treatment without human trial data.

6.3 Antidiarrheal Activity

Evidence level: Preclinical animal studies and molecular docking; no human trials.

Chemical and biological investigations of the stems of the P. chaba plant performed antidiarrheal, antimicrobial, and analgesic assessments. Docking models implied that isolated compounds of P. chaba exert different pharmacological activities by inhibiting targeted receptors. Molecular docking and ADME/T analysis of the alkaloids validated a potent pharmacological basis for the traditional utilization of P. chaba in treating diarrhea, pain, and microbial infection.

6.4 Antidiabetic Activity

Evidence level: In vitro and animal models (streptozotocin-induced diabetes in rats); no human trials.

A study in the Journal of Community Health Research evaluated the antidiabetic potential of P. chaba stem extract. The research examined antidiabetic potential of the P. chaba stem extract in both in vitro and in vivo diabetic models, using cold maceration process. α-Amylase and α-glucosidase inhibition assays were performed; further, in vivo antidiabetic activity was studied using a streptozotocin-induced model. The methanolic extract showed IC₅₀ values of 108.89 μg/ml and 127.28 μg/ml against α-amylase and α-glucosidase, respectively.

Retrofractamide A from Piper chaba has been shown to enhance adipogenesis in 3T3-L1 cells, increasing adiponectin levels and glucose uptake — mechanisms potentially relevant to metabolic syndrome and insulin sensitivity. These findings are preliminary and require clinical validation.

6.5 Hepatoprotective Activity

Evidence level: Animal studies (rodent models); no human trials.

A 2019 study published in Pharmacology and Pharmacy evaluated hepatoprotective effects against paracetamol-induced liver injury. The study evaluated antioxidant and hepatoprotective activities of P. chaba roots. Hepatoprotective effects were demonstrated by significant alteration of serum biomarker enzymes and antioxidant enzymes. Co-administration of P. chaba extract to paracetamol-induced rats resulted in a partial recovery in the serum biochemical parameters (SGOT, SGPT, ALP, and Bilirubin). The ethanolic extract at the lower dose (200 mg/kg b.w.) was more effective than the higher dose of 400 mg/kg b.w. in reducing serum dysfunction biomarker enzymes. Histopathological studies of liver tissues also showed better hepatoprotective activity at the lower dose (200 mg/kg b.w.).

Co-administration of P. chaba at both tested doses with acetaminophen (APAP) significantly reduced the APAP-augmented liver marker enzymes ALT, AST, ALP, and LDH, along with serum albumin, globulin, hepatic enzymes, histopathological architecture, lipid profiles, total protein, and total bilirubin. The hepatoprotective activity of the ethanolic extract of P. chaba roots is likely due to scavenging of free radicals and antioxidant properties, possibly due to the large amount of piperine in the roots. The exact mechanisms of action of hepatoprotection have not been fully investigated.

6.6 Anticancer / Cytotoxic Activity

Evidence level: In vitro cell line studies, in silico modeling; no human trials.

A 2023 study published in PubMed (PMID 37711079) investigated the effect of P. chaba extract on breast cancer cells. Piper chaba (Piperaceae) is a medicinal spice plant that possesses several pharmacological activities. For the first time, the effect of P. chaba extract on breast cancer cells was studied. P. chaba stem methanolic extract produced time- and dose-dependent cytotoxicity in luminal breast cancer cells (MCF-7 and T47D) with minimal toxicity in breast normal cells (MCF-10A) at 10–100 μg/mL concentration. The extract produced IC₅₀ values of 16.79 μg/mL and 31.21 μg/mL for T47D and MCF-7 cells, respectively, in 48 h treatment.

Confocal microscopy showed an increase in late apoptosis in extract-treated breast cancer cells at IC₅₀. An increased caspase 9 and caspase 3/7 enzymatic activity was observed in test cells compared with non-treated cells. The conclusion was that P. chaba phytocompound possesses the potential to induce cell cycle arrest and apoptosis in luminal breast cancer cells.

A 2025 study in Chemistry & Biodiversity used in silico and in vitro approaches. Phytochemicals of P. chaba were found in silico to exert anticancer effects through the inhibition of VEGFR2, HER2, HER3, and IKK beta. These are all laboratory findings; no clinical anticancer evidence in humans has been reported.

6.7 Antimalarial Activity

Evidence level: In vitro parasite cultures; no human trials.

The plant contains various bioactive compounds including piperine and chabamide, with diverse pharmacological activities. Extracts from P. chaba show promising anti-malarial effects against Plasmodium falciparum, with IC₅₀ values of 4.1 and 5.3 μg/mL. A separate study of piperine — the major isolated constituent of Piper chaba fruits — examined antimalarial activity. Piperine was demonstrated to exhibit promising antimalarial activity against the asexual stage of 3D7 (chloroquine-sensitive) and K1 (chloroquine-resistant) P. falciparum clones; the IC₅₀ values of piperine against 3D7 and K1 P. falciparum were 111.5 and 59 μM, respectively.

6.8 Antileishmanial Activity

Evidence level: In vitro studies only.

The petroleum ether and chloroform extracts of the root of Piper chaba showed antimicrobial, antileishmanial, and cytotoxic activities. Bioactivity-guided fractionation led to the isolation of bornyl piperate, piperlonguminine, and piperine. Bornyl piperate and piperlonguminine showed potent antifungal activity exceeding that of Nystatin, and significant cytotoxic activity with IC₅₀ values of 0.76 and 0.83 μg mL⁻¹, respectively. These compounds were also found to have weak antibacterial and antileishmanial activities. This was the first report about the antileishmanial activity of Piper isolates.

6.9 Antioxidant Activity

Evidence level: In vitro assays; no human trials.

The DPPH method demonstrated the highest antioxidant activity with an IC₅₀ of approximately 42.61 ± 1.82 μg/ml in P. chaba from the Uttarakhand region of India. The antioxidant activity of the leaf extract is prominent and important fatty acids have been found in the leaf extract of P. chaba.

6.10 Neurological / Alzheimer's Disease (Computational Only)

Evidence level: In silico (computational) modeling only — no in vitro, animal, or human data reported for this indication.

A 2025 study published in PMC (PMC12259330) used network pharmacology and computational approaches. Through analysis of various signaling pathways, target proteins, and compounds, the involvement of a key signaling pathway (the metabolic signaling pathway) along with three important target proteins (PTGS2, CYP2C19, and PLA2G4A) and five identified compounds was identified. Comparative analysis with positive controls revealed that three compounds from P. chaba exhibited higher affinity towards their respective target proteins, suggesting their potential as novel anti-Alzheimer's agents. While the computational findings provide promising insights into the potential interaction of the identified compounds with AD-related targets, further validation is essential. Future in vitro and in vivo clinical studies are required to confirm the bioactivity of these compounds at the cellular level. The authors themselves confirm this is early-stage investigation.

7. Body Systems and Health Areas Associated with Piper chaba

Based on preclinical and traditional evidence, Piper chaba has been associated with the following body systems:

• Gastrointestinal system: Digestive stimulation, antidiarrheal, antiulcer, carminative, gastrointestinal motility, and hepatoprotective effects.
• Immune and infectious disease: Antimicrobial (antibacterial and antifungal), antileishmanial, antimalarial, and immunomodulatory effects.
• Metabolic system: Antidiabetic effects via α-amylase and α-glucosidase inhibition; adipogenic effects relevant to metabolic syndrome.
• Musculoskeletal / Pain system: Analgesic and anti-inflammatory effects mediated partly via TRPV1 activation and COX-2 inhibition.
• Cardiovascular system: Reported antihypertensive and anticoagulant activities in preclinical studies.
• Oncology (preclinical only): Cytotoxic and pro-apoptotic effects in cancer cell lines.
• Nervous system (computational only): Computational models suggest potential relevance to neurodegeneration.
• Respiratory system: Traditional use for cough, asthma, and bronchitis; limited scientific corroboration.

As summarized in the 2020 review in the Journal of Ethnopharmacology, extracts from P. chaba or derived compounds exhibit diverse biological activities such as anti-microbial, anti-leishmanial, anti-malarial, anti-parasitic, cytotoxic/anticancer, adipogenic, hepato- and gastro-protective, anti-diabetic, analgesic, anti-diarrheal, depressive, anti-inflammatory, diuretic, anti-hypertensive, antipyretic, anti-ulcer, and immunomodulatory effects.

8. Dosage Forms and Study Dosages

The following dosages are reported as used in specific studies and in traditional descriptions; they are not recommendations:

• Methanol extract of stem bark (rodent studies): Evaluated at 125, 250, and 500 mg/kg body weight doses in mice and rats in preliminary pharmacological screening for analgesic, anti-inflammatory, diuretic, anti-diarrhoeal, gastrointestinal motility, and CNS depressant activity.
• Ethanolic root extract (hepatoprotective, rodent study): Ethanolic extract of Piper chaba was tested at 200 mg/kg b.w. and 400 mg/kg b.w. The lower dose (200 mg/kg b.w.) was more effective than the higher dose in reducing serum dysfunction biomarker enzymes and showed better hepatoprotective activity in histopathological studies.
• Methanolic stem extract (in vitro antidiabetic study): IC₅₀ values of 108.89 μg/ml against α-amylase and 127.28 μg/ml against α-glucosidase.
• Stem methanolic extract (breast cancer cells, in vitro): Produced cytotoxicity at 10–100 μg/mL concentration, with IC₅₀ of 16.79 μg/mL for T47D cells and 31.21 μg/mL for MCF-7 cells in 48 h treatment.
• TRPV1 study (cell and mouse): The adjuvant effect of 1% piperine, 5% piperine, 1% PC extract, and 5% PC extract on contact sensitization was investigated using an FITC-induced contact hypersensitivity model.
• Traditional Ayurvedic dosage: Typical dosages from traditional sources range from 1–3 grams of powder daily or 50–100 ml of decoction.

9. Safety Considerations and Interactions

P. chaba is utilized in many foods and does have nutritional and antioxidant qualities. Additionally, P. chaba is said to be edible and nontoxic at food-use levels. However, several specific safety considerations relevant to its use as a concentrated supplement are supported by the literature:

Acute Toxicity

The methanolic extract of P. chaba stem showed good antidiabetic potential in preclinical assays, and the methanolic extract showed no acute toxicity in rats before conducting in vivo experiments. Formal acute and chronic toxicity studies in established animal models at full regulatory-grade level have not been broadly published for P. chaba; this is a gap in the current safety evidence.

Piperine-Mediated Drug Interactions

Piperine — the dominant alkaloid in P. chaba — has the ability to alter gastrointestinal disorders, drug-metabolizing enzymes, and the bioavailability of several drugs. This is of clinical significance: piperine is known to inhibit cytochrome P450 enzymes and P-glycoprotein, which can increase blood levels of co-administered drugs. The CYP2E1-inhibiting activity demonstrated by P. chaba extracts in silico may contribute to altered hepatic metabolism of other substrates.

TRPV1-Mediated Skin Sensitization

P. chaba extract and piperine significantly enhanced sensitization to FITC as revealed by ear swelling responses in a mouse contact hypersensitivity model. P. chaba extract and piperine activated the TRPV1 channel and enhanced contact sensitization to FITC. This suggests that topical application or internal use in sensitized individuals may amplify contact hypersensitivity reactions — a pharmacological adjuvant effect relevant to persons with pre-existing allergic conditions.

Gastrointestinal Irritation

People with Pitta imbalance may not tolerate this spicy root. It may cause or worsen gastritis, burning sensation in the stomach, throat, palm, and feet. Long-term usage of this herb is considered best avoided in traditional Ayurvedic guidance.

Concentration-Dependent Cytotoxicity

Extracts of P. chaba have been studied for cytotoxic activities by brine shrimp lethality bioassay, where the petroleum ether extract was found to be potently cytotoxic with an LC₅₀ value of 0.95 μg/ml against Artemia salina. While the brine shrimp assay is a standard preliminary screen and does not directly translate to human toxicity, this finding indicates that highly concentrated extracts may carry cytotoxic potential.

Status of Regulatory Oversight

As of the available literature search, Piper chaba does not appear to be the subject of a completed WHO monograph, European Medicines Agency (EMA) assessment, or an NIH Office of Dietary Supplements monograph as a standalone ingredient. Its use is primarily documented within the framework of traditional Ayurvedic, Unani, and Bangladeshi folk medicine systems. No large-scale randomized controlled clinical trials have been published evaluating safety or efficacy in human subjects.

References

• Islam et al. (2024). Isolation, Structure Elucidation, and Bioactivity Evaluation of Two Alkaloids From Piper chaba H. Stem. PMC11666819 — PubMed Central
• Islam MT et al. (2020). Chemical profile, traditional uses, and biological activities of Piper chaba Hunter: A review. Journal of Ethnopharmacology, 257. ScienceDirect
• Hossain ML et al. (2005). Preliminary pharmacological studies on Piper chaba stem bark. PubMed PMID 15894128
• Kumar S et al. (2023). Piper chaba, an Indian spice plant extract, inhibits cell cycle G1/S phase transition and induces intrinsic apoptotic pathway in luminal breast cancer cells. PubMed PMID 37711079
• Panthong A et al. (2020). The role of Piper chaba Hunt. and its pure compound, piperine, on TRPV1 activation and adjuvant effect. BMC Complementary Medicine and Therapies. PMC7201532
• Joshi H et al. (2024). GC–MS fingerprinting, nutritional composition, in vitro pharmacological activities and molecular docking studies of Piper chaba from Uttarakhand region. PMC11101386 — PubMed Central
• Al-Rashidi et al. (2025). Unveiling the Therapeutic Potential of Piper chaba Hunter: Computational Approaches Shed Light on Targeting Proteins in Alzheimer's Disease. PMC12259330 — PubMed Central
• Ittarat W et al. (2019). Antimalarial Activity of Piperine. PMC6304611 — PubMed Central
• Naz T et al. (2012). Antimicrobial, antileishmanial and cytotoxic compounds from Piper chaba. Natural Product Research 26(11):979–986. PubMed PMID 21834629
• Yesmin S et al. (2019). Antioxidant Activity and Hepatoprotective Potential of Piper chaba Roots against Paracetamol-Induced Liver Injury. Pharmacology and Pharmacy 10(11):484–497. SCIRP
• Islam R et al. (2022). GC–MS analysis and evaluation of protective effect of Piper chaba stem bark against paracetamol-induced liver damage: possible mechanism by targeting CYP2E1. Life Sciences. ScienceDirect
• Maiti MK et al. (2026). Antioxidant, antidiabetic, and anti-inflammatory activities of Piper chaba stem extracts and metabolomic profile by GC–MS and HPTLC. Vegetos 39:318–331. Springer
• Choudhary N et al. (2022). Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials. PMC8796742 — PubMed Central
• GBIF Backbone Taxonomy: Piper retrofractum Vahl — Global Biodiversity Information Facility
• Piper retrofractum — Wikipedia
• Cavya: 12 definitions — wisdomlib.org (Ayurvedic classical text references)
• Chavya – Piper retrofractum Uses, Research, Side Effects — Easy Ayurveda
• Joshi S et al. (2025). Identification of Potential Anticancer Phytochemicals of Piper chaba by Comprehensive Molecular Docking, Molecular Dynamics Simulation and In-Vitro Studies. Chemistry & Biodiversity. Wiley Online Library
• Bioactive compounds of Piper chaba and their pharmacological relevance: a phytochemistry-focused review. Phytochemistry Reviews. Springer (2025)
• Chemical composition, antioxidant and antibacterial activity of Piper chaba stem extracts with preservative effects on storage of raw beef patties. Saudi Journal of Biological Sciences. PMC10196701